CPA6 is a gene encoding carboxypeptidase A6. This protein is expressed in the developing brain and helps to regulate the activities of a variety of proteins. The effects of specific mutations in CPA6 can be ascertained by introducing a replica of the gene containing a particular mutation into cells and then assessing the behavior of those cells.

We are pleased to offer our mutation characterization and drug screening services for eligible pathogenic mutations within CPA6. Please contact us with interests and inquiries.